CochLear PE Ratio 2023-2024 | CHEOY
Current and historical p/e ratio for CochLear (CHEOY) from 2023 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CochLear PE ratio as of August 14, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CochLear PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-14 | 101.68 | 0.00 | |
| 2024-12-31 | 89.02 | 0 | 0.00 |
| 2024-06-30 | 109.21 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.302B | $1.488B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.755B | 27.77 |
| CVS Health (CVS) | United States | $83.583B | 10.39 |
| Elevance Health (ELV) | United States | $66.299B | 8.92 |
| Cencora (COR) | United States | $56.410B | 18.79 |
| DiDi Global (DIDIY) | China | $26.262B | 27.90 |
| Labcorp Holdings (LH) | United States | $22.648B | 18.00 |
| Natera (NTRA) | United States | $21.644B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.857B | 0.00 |
| ICON (ICLR) | Ireland | $14.237B | 13.70 |
| Medpace Holdings (MEDP) | United States | $13.148B | 34.80 |
| Solventum (SOLV) | United States | $12.897B | 13.31 |
| Viatris (VTRS) | United States | $12.137B | 4.32 |
| Revvity (RVTY) | United States | $10.554B | 18.59 |
| Caris Life Sciences,�Inc (CAI) | United States | $9.640B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.130B | 0.00 |
| Avantor (AVTR) | United States | $8.910B | 13.07 |
| HealthEquity (HQY) | United States | $7.720B | 33.81 |
| Charles River Laboratories (CRL) | United States | $7.628B | 14.47 |
| Bausch + Lomb (BLCO) | Canada | $5.016B | 33.74 |
| Sotera Health (SHC) | United States | $4.465B | 24.95 |
| BrightSpring Health Services (BTSG) | United States | $3.966B | 30.26 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.536B | 80.99 |
| Surgery Partners (SGRY) | United States | $3.021B | 38.00 |
| Concentras Parent (CON) | United States | $2.930B | 18.58 |
| Alignment Healthcare (ALHC) | United States | $2.923B | 0.00 |
| Organon (OGN) | United States | $2.433B | 2.65 |
| Premier (PINC) | United States | $2.020B | 15.33 |
| Progyny (PGNY) | United States | $1.983B | 41.93 |
| Ardent Health (ARDT) | United States | $1.813B | 7.00 |
| PACS (PACS) | United States | $1.750B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.350B | 9.01 |
| Teladoc Health (TDOC) | United States | $1.315B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.272B | 20.94 |
| Establishment Labs Holdings (ESTA) | $1.111B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.815B | 4.77 |
| AMN Healthcare Services Inc (AMN) | United States | $0.714B | 8.83 |
| CareDx (CDNA) | United States | $0.646B | 11.89 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.584B | 8.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
| So-Young (SY) | China | $0.517B | 0.00 |
| Omada Health (OMDA) | $0.517B | 0.00 | |
| InnovAge Holding (INNV) | United States | $0.494B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 10.50 |
| SBC Medicals (SBC) | United States | $0.447B | 9.81 |
| Agilon Health (AGL) | United States | $0.435B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.384B | 25.23 |
| Oncology Institute (TOI) | United States | $0.366B | 0.00 |
| LifeMD (LFMD) | United States | $0.327B | 0.00 |
| Beauty Health (SKIN) | United States | $0.300B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.176B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.132B | 0.00 |
| KindlyMD (NAKA) | United States | $0.101B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.056B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.043B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| ModivCare (MODV) | United States | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |